1.Distribution of neuronal nitric oxide synthase-immunopositive neurons in rat corpus striatum and their ultrastructures.
Guo-Qing GUO ; Ai-Jing SHAN ; Wei-Zai SHEN ; Xiao-Zhong QIU ; Lei YU ; Jian-Qiang QIN ; Jun OUYANG ; Hua LIAO ; Shi-Zhen ZHONG
Journal of Southern Medical University 2007;27(1):1-4
OBJECTIVETo observe the distribution of neuronal nitric oxide synthase (nNOS)-immunopositive neurons in rat corpus striatum and their ultrastructural features.
METHODSBrain tissue specimens were obtained from normal SD rats, in which nNOS-immunopositive neurons were visualized by ABC immunocytochemistry and observed under immunoelectron microscope with pre-embedding staining.
RESULTSUnder light microscope, nNOS-immunopositive neurons appeared brown with distinct profiles of the cell body and processes. These neurons, mostly medium-sized and small cells, were located mainly in the lateral region of the corpus striatum. Only a few immunopositive neurons were detected in the medial region of the corpus striatum. Immunohistochemistry and transmission electron microscopy identified the nNOS-immunopositive neurons as interneurons possessing large nuclei with small amount of cytoplasma. The immunopositive granules were visualized as black plaques, and the larger ones distributed mainly in the cell bodies, some with monolayer membrane encapsulation. The small granules did not have the encapsulation, scattering in perinuclear regions and under the cell membrane, but not in the cell body. The immunopositive granules were also found in the axons and dendrites, but not in the vesicles of the synapses. In addition, many immunopositive terminals were found close to the blood vessels.
CONCLUSIONSnNOS-immunopositive neurons in rat corpus striatum are mainly medium-sized and small cells as is typical of the interneurons. The immunopositive granules locate in the cytoplasma, axons and dendrites, and larger granules have membrane coating while small ones do not, possibly in relation to their functions.
Animals ; Corpus Striatum ; enzymology ; ultrastructure ; Immunohistochemistry ; Male ; Microscopy, Electron, Transmission ; Neurons ; enzymology ; ultrastructure ; Nitric Oxide Synthase Type I ; metabolism ; Rats ; Rats, Sprague-Dawley
2.Effect of Carbon Monoxide-Induced Hypoxia on Synaptosomal Uptake and Release of Dopamine in Rat Striatum.
Kyoung Ja CHAI ; Soo Kyung BAE
Yonsei Medical Journal 1988;29(2):129-138
We studied the effect of carbon monoxide (CO)-induced hypoxia on synaptosomal uptake and release of dopamine (DA) in rat striatum. When the rats were intoxicated at a blood level of carboxyhemoglobin (HbCO), 60-70% for 3-4hrs, [3H] DA uptake was inhibited as much as 80% of control activity. This suppressed activity remained as long as 12 hrs after termination of the intoxication. After a week recovery period, the suppressed uptake activity was restored completely. When the rats were intoxicated maintaining a blood level of HbCO at 30-40% for 6-7hrs, the uptake was inhibited to 57% of the control actvity and this suppressed activity was restored within 12hrs. For the rats maintaining a blood level of HbCO at 15-25% for 6-7hrs, uptake inhibition was not shown. Acute CO intoxication(at 60-70% of HbCO for 3-4 hrs) caused an increase in K+-stimulated DA release to 147% of the control value. In conclusion, the diminished uptake and increased release of striatal DA in a CO intoxicated brain would cause an extraneuronal accumulation of DA with depletion of intraneuronal DA level, which may play a role in CO-induced hypoxic cell damage.
Animal
;
Carbon Monoxide Poisoning/*complications
;
Corpus Striatum/*ultrastructure
;
Culture Media
;
Dopamine/*metabolism
;
Female
;
Hypoxia, Brain/chemically induced/*pathology
;
In Vitro
;
Male
;
Rats
;
Synaptosomes/*metabolism
3.The microglia activation characteristics of MA-induced neurotoxicity in the rats striatum.
Dong-Fang QIAO ; Yan-Hong LI ; Xiao-Hui TAN ; Hui-Jun WANG
Journal of Forensic Medicine 2009;25(5):321-325
OBJECTIVE:
To investigate the activation characteristics of microglia (MG) in the rats striatum with MA-induced neurotoxicity.
METHODS:
Male Wistar rats were divided randomly into control group (n=24) and experimental group (n=24). The rats of experimental group were injected intraperitoneally with MA (15 mg/kg x 8 injections, at 12 hours interval). The rats of control group were administrated with saline. The tissues of striatum of two rat groups were harvested at 0.5 d, 1 d, 2 d, 3 d, 4 d, 5 d, 6 d and 7 d post initial administrations of MA or saline. The structure changes were observed by transmission electron microscopy and CD-11b immunohistochemistry. The ratio of activated MG was calculated and statistically analyzed.
RESULTS:
In the control group, the morphological characteristics of the MG showed that the cell bodies were small with slender processes, high electronic density nucleus, and fewer organelles known as the "fork-type". In contrast, the MG in the MA-induced neurotoxicity group displayed larger cell body, shorter cell processes or disappeared, lower electronic density nucleus and rich organelles, resembling "bush-like" or "amoeba-like". The ratio of activated MG in control group was below 0.15 at all timepoints, whereas in the experimental group, the ratio of activated MG increased significantly from day 1 to day 7 (P<0.001).
CONCLUSION
The continuous MA stimulation of the CNS results in prominent MG activation.
Animals
;
Corpus Striatum/pathology*
;
Immunohistochemistry
;
Male
;
Methamphetamine/toxicity*
;
Microglia/ultrastructure*
;
Microscopy, Electron, Scanning
;
Random Allocation
;
Rats
;
Rats, Wistar
;
Staining and Labeling
;
Time Factors
4.Neuroprotection by scorpion venom heat resistant peptide in 6-hydroxydopamine rat model of early-stage Parkinson's disease.
Sheng-Ming YIN ; Dan ZHAO ; De-Qin YU ; Sheng-Long LI ; Dong AN ; Yan PENG ; Hong XU ; Yi-Ping SUN ; Dong-Mei WANG ; Jie ZHAO ; Wan-Qin ZHANG
Acta Physiologica Sinica 2014;66(6):658-666
Neuroprotective effect of scorpion venom on Parkinson's disease (PD) has already been reported. The present study was aimed to investigate whether scorpion venom heat resistant peptide (SVHRP) could attenuate ultrastructural abnormalities in mitochondria and oxidative stress in midbrain neurons of early-stage PD model. The early-stage PD model was established by injecting 6-hydroxydopamine (6-OHDA) (20 μg/3 μL normal saline with 0.1% ascorbic acid) into the striatum of Sprague Dawley (SD) rats unilaterally. The rats were intraperitoneally administered with SVHRP (0.05 mg/kg per day) or vehicle (saline) for 1 week. Two weeks after 6-OHDA treatment, the rats received behavior tests for validation of model. Three weeks after 6-OHDA injection, the immunoreactivity of dopaminergic neurons were detected by immunohistochemistry staining, and the ultrastructure of neuronal mitochondria in midbrain was observed by electron microscope. In the meantime, the activities of monoamine oxidase-B (MAO-B), superoxide dismutase (SOD) and content of malondialdehyde (MDA) in the mitochondria of the midbrain neurons, as well as the inhibitory ability of hydroxyl free radical and the antioxidant ability in the serum, were measured by corresponding kits. The results showed that 6-OHDA reduced the optical density of dopaminergic neurons, induced damage of mitochondrial ultrastructure of midbrain neurons, decreased SOD activity, increased MAO-B activity and MDA content, and reduced the antioxidant ability of the serum. SVHRP significantly reversed the previous harmful effects of 6-OHDA in early-stage PD model. These findings indicate that SVHRP may contribute to neuroprotection by preventing biochemical and ultrastructure damage changes which occur during early-stage PD.
Animals
;
Antioxidants
;
metabolism
;
Corpus Striatum
;
Disease Models, Animal
;
Dopaminergic Neurons
;
drug effects
;
Malondialdehyde
;
metabolism
;
Mesencephalon
;
cytology
;
Mitochondria
;
metabolism
;
ultrastructure
;
Neuroprotective Agents
;
pharmacology
;
Oxidative Stress
;
Oxidopamine
;
Parkinson Disease
;
drug therapy
;
Peptides
;
pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Scorpion Venoms
;
pharmacology
;
Superoxide Dismutase
;
metabolism